首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1608867

牛市場：按應用、按最終用戶、按地區

Fetal Bovine Serum Market, By Application, By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, and Others), By Geography

出版日期: 2024年11月19日 | 出版商:

Coherent Market Insights | 英文 162 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

牛市場預計到2024年為18.6億美元，預計到2031年將達到45.4億美元，2024年至2031年的複合年成長率為13.6%。

分析範圍		分析詳情
基準年	2023年	市場規模（2024年）	18.6億美元
實際資料	2019-2023	預測期	2024-2031
預測期複合年成長率（2024-2031）	13.60%	預計金額（2031年）	45.4億美元

圖：2024年按地區牛的胎牛血清市場佔有率（%）

牛是一種重要的細胞培養基補充品，用於科學研究和各種醫療過程。它源自於從懷孕六個月左右宰殺的懷孕牛身上收集的胎兒血液中獲得的胎兒血細胞。牛(FBS) 含有多種對細胞存活、生長和增殖至關重要的生長因子、蛋白質、黏附素和維生素。對生物製藥的需求不斷成長以及對細胞研究的日益關注正在推動全球牛市場的成長。

市場動態：

全球牛市場的成長是由生物製藥需求的增加和生命科學產業研究活動的活性化所推動的。生物製藥生產在很大程度上依賴牛來培養和維持最佳的細胞培養條件。慢性病盛行率的不斷上升推動了對開發新藥的需求，這需要利用牛進行廣泛的研究工作。然而，價格波動和對畜牧業動物福利實踐的道德擔憂可能會阻礙市場成長。此外，向無血清和無異源細胞培養基的轉變為牛市場帶來了挑戰。然而，對個人化醫療、再生療法和幹細胞研究的日益關注預計將在預測期內提供顯著的成長機會。

本研究的主要特點

本報告對全球牛市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。

它還闡明了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

根據公司亮點、產品系列、主要亮點、績效和策略等參數，提供全球牛市場主要企業的概況。

主要公司包括 Merck KGaA、Thermo Fisher Scientific Inc.、HiMedia Laboratories、Bio-Techne、PAN-Biotech、Atlas Biologicals, Inc.、Rocky Mountain Biologicals、Cytiva、Sartorius AG 和 SeraCare Life Sciences。

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

本報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

相關人員可以透過分析全球牛市場時所使用的各種策略矩陣來促進決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	1.86 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	13.60%	2031 Value Projection:	4.54 Bn

Fetal bovine serum is an important cell culture media supplement used in scientific research and various medical processes. It is derived from fetal blood cells obtained from fetal blood collected from slaughtered pregnant cattle around 6 months of gestation. Fetal bovine serum (FBS) contains various growth factors, proteins, attachment factors, and vitamins essential for cell survival, growth, and proliferation. The increasing demand for biopharmaceuticals and rising focus on cell-based research is driving the growth of the fetal bovine serum market globally.

Market Dynamics:

The global fetal bovine serum market growth is driven by the rising demand for biopharmaceuticals and increasing research activities in life science industries. Biopharmaceutical production heavily relies on fetal bovine serum for growing and maintaining optimal cell culture conditions. Rising prevalence of chronic diseases is propelling the demand for new drug development which requires extensive research activities utilizing fetal bovine serum. However, price fluctuations in cattle farming and ethical concerns regarding animal welfare practices could hamper the market growth. Also, a shift towards serum-free and xeno-free cell culture mediums presents challenges to the fetal bovine serum market. Nonetheless, the growing focus on personalized medicine, regenerative therapies, and stem cell research are expected to present significant growth opportunities over the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global fetal bovine serum market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global fetal bovine serum market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., HiMedia Laboratories, Bio-Techne, PAN-Biotech, Atlas Biologicals, Inc., Rocky Mountain Biologicals, Cytiva, Sartorius AG, and SeraCare Life Sciences

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global fetal bovine serum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fetal bovine serum market

Market Segmentation

Application Insights (Revenue, USD Bn, 2019 - 2031)
- Drug Discovery
- In-vitro Fertilization
- Vaccine Production
- Cell-based Research
- Diagnosis
- Others
End User Insights (Revenue, USD Bn, 2019 - 2031)
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CRO)
- Academic And Research Institutes
- Others
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Merck KGaA
- Thermo Fisher Scientific Inc.
- HiMedia Laboratories
- Bio-Techne
- PAN-Biotech
- Atlas Biologicals, Inc.
- Rocky Mountain Biologicals
- Cytiva
- Sartorius AG
- SeraCare Life Sciences

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Fetal Bovine Serum Market, By Application
- Fetal Bovine Serum Market, By End User
- Fetal Bovine Serum Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Market Trends

4. Global Fetal Bovine Serum Market, By Application, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
In-vitro Fertilization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Vaccine Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cell-based Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Fetal Bovine Serum Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Contract Research Organizations (CRO)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Academic And Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Fetal Bovine Serum Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HiMedia Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Techne
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PAN-Biotech
Atlas Biologicals, Inc.
Rocky Mountain Biologicals
Cytiva
Sartorius AG
SeraCare Life Sciences